Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353–65.

Article  PubMed  Google Scholar 

Liu C, Liu T, Zhang Z, Zhang N, Du P, Yang Y, et al. (68)ga-psma pet/ct combined with pet/ultrasound-guided prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsy results. J Nucl Med. 2020;61:1314–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric mri and trus biopsy in prostate cancer (promis): A paired validating confirmatory study. Lancet. 2017;389:815–22.

Article  PubMed  Google Scholar 

Xing NZ, Wang MS, Fu Q, Yang FY, Li CL, Li YJ, et al. Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques. World J Clin Cases. 2019;7:1403–9.

Article  PubMed  PubMed Central  Google Scholar 

Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. 2022;82:156–60.

Article  PubMed  Google Scholar 

Wang C, Yuan L, Shen D, Zhang B, Wu B, Zhang P, et al. Combination of pi-rads score and psad can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. Front Oncol. 2022;12:1024204.

Article  PubMed  PubMed Central  Google Scholar 

Distler FA, Radtke JP, Bonekamp D, Kesch C, Schlemmer HP, Wieczorek K, et al. The value of psa density in combination with pi-rads™ for the accuracy of prostate cancer prediction. J Urol. 2017;198:575–82.

Article  PubMed  Google Scholar 

Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, et al. Combination of prostate imaging reporting and data system (pi-rads) score and prostate-specific antigen (psa) density predicts biopsy outcome in prostate biopsy naïve patients. BJU Int. 2017;119:225–33.

Article  CAS  PubMed  Google Scholar 

Wang CM, Yuan L, Liu XH, Chen SQ, Wang HF, Dong QF, et al. Developing a diagnostic model for predicting prostate cancer: A retrospective study based on chinese multicenter clinical data. Asian J Androl. 2023;26:34–40.

Article  PubMed  PubMed Central  Google Scholar 

Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (primary): A prospective multicentre study. Eur Urol. 2021;80:682–9.

Article  CAS  PubMed  Google Scholar 

Tang W, Tang Y, Qi L, Zhang Y, Tang G, Gao X, et al. Benign prostatic hyperplasia-related false-positive of prostate-specific membrane antigen-positron emission tomography in the diagnosis of prostate cancer: The achilles’ heel of biopsy-free radical prostatectomy? J Urol. 2023;210:845–55.

Article  PubMed  Google Scholar 

Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, et al. Head-to-head comparison of (68)ga-psma-11 with (18)f-psma-1007 pet/ct in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard. J Nucl Med. 2020;61:527–32.

Article  CAS  PubMed  Google Scholar 

Kesch C, Vinsensia M, Radtke JP, Schlemmer HP, Heller M, Ellert E, et al. Intraindividual comparison of (18)f-psma-1007 pet/ct, multiparametric mri, and radical prostatectomy specimens in patients with primary prostate cancer: A retrospective, proof-of-concept study. J Nucl Med. 2017;58:1805–10.

Article  CAS  PubMed  Google Scholar 

Wang C, Dong Q, Liu X, Ni M, Xie Q, Xiao J, et al. Protocol for snotob study: radical prostatectomy without prostate biopsy following (18)f-psma-1007 pet/ct based on a diagnostic model: A single-centre, single-arm, open-label study. BMJ Open. 2023;13:e073983.

Article  PubMed  PubMed Central  Google Scholar 

Bossuyt, Reitsma PM, Bruns DE JB, Gatsonis CA, Glasziou PP, Irwig L, et al. Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. Bmj. 2015;351:h5527.

Article  PubMed  PubMed Central  Google Scholar 

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76:340–51.

Article  PubMed  Google Scholar 

Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, et al. E-psma: the eanm standardized reporting guidelines v1.0 for psma-pet. Eur J Nucl Med Mol Imaging. 2021;48:1626–38.

Article  PubMed  PubMed Central  Google Scholar 

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 international society of urological pathology (isup) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244–52.

Article  PubMed  Google Scholar 

Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl J Med. 2023;388:1547–58.

Article  PubMed  Google Scholar 

Briganti A, Fossati N, Catto JWF, Cornford P, Montorsi F, Mottet N, et al. Active surveillance for low-risk prostate cancer: The european association of urology position in 2018. Eur Urol. 2018;74:357–68.

Article  PubMed  Google Scholar 

Beatrici E, Labban M, Stone BV, Filipas DK, Reis LO, Lughezzani G, et al. Uncovering the changing treatment landscape for low-risk prostate cancer in the USA from 2010 to 2020: Insights from the national cancer data base. Eur Urol. 2023;84:527–30.

Article  PubMed  Google Scholar 

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. Eau-eanm-estro-esur-siog guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62.

Article  CAS  PubMed  Google Scholar 

Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, et al. What are we missing? False-negative cancers at multiparametric mr imaging of the prostate. Radiology. 2018;286:186–95.

Article  PubMed  Google Scholar 

Sathianathen NJ, Omer A, Harriss E, Davies L, Kasivisvanathan V, Punwani S, et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur Urol. 2020;78:402–14.

Article  PubMed  Google Scholar 

Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, et al. Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: A systematic review and meta-analysis. Eur Urol Oncol. 2021;4:697–713.

Article  PubMed  Google Scholar 

Yilmaz EC, Shih JH, Belue MJ, Harmon SA, Phelps TE, Garcia C, et al. Prospective evaluation of pi-rads version 2.1 for prostate cancer detection and investigation of multiparametric mri-derived markers. Radiology. 2023;307:e221309.

Article  PubMed  Google Scholar 

Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, et al. Psma ligands for pet imaging of prostate cancer. J Nucl Med. 2017;58:1545–52.

Article  CAS  PubMed  Google Scholar 

Wagaskar VG, Mittal A, Sobotka S, Ratnani P, Lantz A, Falagario UG, et al. Hood technique for robotic radical prostatectomy-preserving periurethral anatomical structures in the space of retzius and sparing the pouch of douglas, enabling early return of continence without compromising surgical margin rates. Eur Urol. 2021;80:213–21.

Article  PubMed  Google Scholar 

Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. Eau-eanm-estro-esur-isup-siog guidelines on prostate cancer-2024 update. Part i: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148–63.

Article  PubMed  Google Scholar 

Olah C, Mairinger F, Wessolly M, Joniau S, Spahn M, Kruithof-de Julio M, et al. Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. Prostate Cancer Prostatic Dis. 2024. https://doi.org/10.1038/s41391-024-00918-9

Article  PubMed